Differentiation and treatment ideas of the comorbidity of hyperuricemia and erectile dysfunction from the perspective of "deficiency, stasis, and turbidity"
SUN LONGJI, LI HAISONG, FENG WEIDONG, et al. Differentiation and treatment ideas of the comorbidity of hyperuricemia and erectile dysfunction from the perspective of "deficiency, stasis, and turbidity". [J]. Beijing journal of traditional chinese medicine, 2025, 44(1): 19-22.
SUN LONGJI, LI HAISONG, FENG WEIDONG, et al. Differentiation and treatment ideas of the comorbidity of hyperuricemia and erectile dysfunction from the perspective of "deficiency, stasis, and turbidity". [J]. Beijing journal of traditional chinese medicine, 2025, 44(1): 19-22. DOI: 10.16025/j.1674-1307.2025.01.004.
LONG H, JIANG J, XIA J, et al. Hyperuricemia is an independent risk factor for erectile dysfunction[J]. J Sex Med, 2016,13(7):1056-1062.
TOTARO M, DIMARAKIS S, CASTELLINI C, et al. Erectile dysfunction in hyperuricemia: a prevalence meta-analysis and meta-regression study[J]. Andrology, 2022,10(1):72-81.
WANG W, JING Z, LIU W, et al. Hyperuricaemia is an important risk factor of the erectile dysfunction:a systematic review and meta-analysis[J].Andrologia, 2022,54(5):e14384.
LEE SY, GONG EY, HONG CY, et al. ROS inhibit the expression of testicular steroidogenic enzyme genes via the suppression of Nur77 transactivation[J]. Free Radic Biol Med, 2009,47(11):1591-1600.
ZHOU Y, ZHAO M, PU Z, et al. Relationship between oxidative stress and inflammation in hyperuricemia: Analysis based on asymptomatic young patients with primary hyperuricemia[J]. Medicine (Baltimore), 2018,97(49):e13108.